{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:45:17Z","timestamp":1792266317851,"version":"4.4.0"},"reference-count":247,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203343"],"award-info":[{"award-number":["82203343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82606606"],"award-info":[{"award-number":["82606606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20220273"],"award-info":[{"award-number":["BX20220273"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M712874"],"award-info":[{"award-number":["2022M712874"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Youth Project of Henan Province Natural Science Foundation","award":["252300421123"],"award-info":[{"award-number":["252300421123"]}]},{"name":"Young Scientist Foundation of State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer","award":["2025SGAQZ-QN-01"],"award-info":[{"award-number":["2025SGAQZ-QN-01"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["262300422369"],"award-info":[{"award-number":["262300422369"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06473-x","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:32:57Z","timestamp":1792143177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From HPV infection to cervical precancer: Molecular mechanisms, immune microenvironment and emerging technologies"],"prefix":"10.1007","volume":"83","author":[{"given":"Yubing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8474-0494","authenticated-orcid":false,"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"6473_CR1","doi-asserted-by":"publisher","unstructured":"Fernandes A, Viveros-Carre\u00f1o D, Hoegl J, \u00c1vila M, Pareja R (2022) Human papillomavirus-independent cervical cancer. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society vol. 32 1\u20137 Preprint at https:\/\/doi.org\/10.1136\/ijgc-2021-003014","DOI":"10.1136\/ijgc-2021-003014"},{"key":"6473_CR2","volume":"8","author":"F Kokka","year":"2022","unstructured":"Kokka F et al (2022) Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev 8:CD010260","journal-title":"Cochrane Database Syst Rev"},{"key":"6473_CR3","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1158\/1078-0432.CCR-20-2833","volume":"27","author":"L Ferrall","year":"2021","unstructured":"Ferrall L, Lin KY, Roden RBS, Hung C-F, Wu T-C (2021) Cervical cancer immunotherapy: facts and hopes. Clin Cancer Res 27:4953\u20134973","journal-title":"Clin Cancer Res"},{"key":"6473_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02965-w","volume":"21","author":"SJ Bowden","year":"2023","unstructured":"Bowden SJ et al (2023) Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC Med 21:274","journal-title":"BMC Med"},{"key":"6473_CR5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D et al (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114\u20132119","journal-title":"JAMA"},{"key":"6473_CR6","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890\u2013907","journal-title":"Lancet"},{"key":"6473_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31829b61d6","author":"RP Berkowitz","year":"2013","unstructured":"Berkowitz RP (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol vol. https:\/\/doi.org\/10.1097\/AOG.0b013e31829b61d6. 122 393 Preprint at","journal-title":"Obstet Gynecol vol"},{"key":"6473_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet 393:169\u2013182","journal-title":"Lancet"},{"key":"6473_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei J et al (2020) HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med 383:1340\u20131348","journal-title":"N Engl J Med"},{"key":"6473_CR10","doi-asserted-by":"publisher","first-page":"e070115","DOI":"10.1136\/bmj-2022-070115","volume":"379","author":"L Rahangdale","year":"2022","unstructured":"Rahangdale L, Mungo C, O\u2019Connor S, Chibwesha CJ (2022) Brewer, N. T. Human papillomavirus vaccination and cervical cancer risk. BMJ 379:e070115","journal-title":"BMJ"},{"key":"6473_CR11","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1016\/j.ejca.2013.04.024","volume":"49","author":"S Vaccarella","year":"2013","unstructured":"Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F (2013) Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer 49:3262\u20133273","journal-title":"Eur J Cancer"},{"key":"6473_CR12","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"360","author":"K Tainio","year":"2018","unstructured":"Tainio K et al (2018) Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ 360:k499","journal-title":"BMJ"},{"key":"6473_CR13","doi-asserted-by":"publisher","first-page":"e069616","DOI":"10.1136\/bmjopen-2022-069616","volume":"13","author":"A Ibrahim Khalil","year":"2023","unstructured":"Ibrahim Khalil A, Zhang L, Muwonge R, Sauvaget C, Basu P (2023) Efficacy and safety of therapeutic HPV vaccines to treat CIN 2\/CIN 3 lesions: a systematic review and meta-analysis of phase II\/III clinical trials. BMJ Open 13:e069616","journal-title":"BMJ Open"},{"key":"6473_CR14","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","volume":"386","author":"CL Trimble","year":"2015","unstructured":"Trimble CL et al (2015) Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet 386:2078\u20132088","journal-title":"Lancet"},{"key":"6473_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/v15071440","author":"A-L Williamson","year":"2023","unstructured":"Williamson A-L (2023) Recent developments in human papillomavirus (HPV) vaccinology. Viruses. https:\/\/doi.org\/10.3390\/v15071440","journal-title":"Viruses"},{"key":"6473_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fonc.2019.00682","volume":"9","author":"C Zhou","year":"2019","unstructured":"Zhou C, Tuong ZK, Frazer IH (2019) Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System. Front Oncol 9:682","journal-title":"Front Oncol"},{"key":"6473_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550\u2013560","journal-title":"Nat Rev Cancer"},{"key":"6473_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2537","volume":"34","author":"J Wolf","year":"2024","unstructured":"Wolf J et al (2024) Human papillomavirus infection: epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Rev Med Virol 34:e2537","journal-title":"Rev Med Virol"},{"issue":"14","key":"6473_CR19","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.3390\/ijms23147903","volume":"23","author":"L Yu","year":"2022","unstructured":"Yu L, Majerciak V, Zheng Z-M (2022) HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation. Int J Mol Sci 23(14):7903","journal-title":"Int J Mol Sci"},{"key":"6473_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13027-018-0199-0","volume":"13","author":"C Annunziata","year":"2018","unstructured":"Annunziata C et al (2018) Prevalence of \u2018unclassified\u2019 HPV genotypes among women with abnormal cytology. Infect Agent Cancer 13:26","journal-title":"Infect Agent Cancer"},{"key":"6473_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S (2017) Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 141:664\u2013670","journal-title":"Int J Cancer"},{"key":"6473_CR22","volume":"5","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Xu L, Simoens C, Martin-Hirsch PP (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 5:CD009069","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"6473_CR23","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"J Doorbar","year":"2012","unstructured":"Doorbar J et al (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30(5):F55\u201370","journal-title":"Vaccine"},{"key":"6473_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC (2013) Human papillomavirus and cervical cancer. Lancet 382:889\u2013899","journal-title":"Lancet"},{"key":"6473_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ygyno.2010.01.024","volume":"117","author":"M Stanley","year":"2010","unstructured":"Stanley M (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol 117:5\u201310","journal-title":"Gynecol Oncol"},{"key":"6473_CR26","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","volume":"283","author":"TV Ellerbrock","year":"2000","unstructured":"Ellerbrock TV et al (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283:1031\u20131037","journal-title":"JAMA"},{"issue":"Suppl 5","key":"6473_CR27","doi-asserted-by":"publisher","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","volume":"30","author":"LA Denny","year":"2012","unstructured":"Denny LA et al (2012) Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 30(Suppl 5):F168\u2013F174","journal-title":"Vaccine"},{"key":"6473_CR28","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1158\/1055-9965.EPI-08-1186","volume":"18","author":"Cervical carcinoma and","year":"2009","unstructured":"Cervical carcinoma and (2009) sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev 18:1060\u20131069","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6473_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","volume":"361","author":"JS Smith","year":"2003","unstructured":"Smith JS et al (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361:1159\u20131167","journal-title":"Lancet"},{"key":"6473_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","volume":"359","author":"V Moreno","year":"2002","unstructured":"Moreno V et al (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 359:1085\u20131092","journal-title":"Lancet"},{"key":"6473_CR31","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","volume":"370","author":"P Appleby","year":"2007","unstructured":"Appleby P et al (2007) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370:1609\u20131621","journal-title":"Lancet"},{"key":"6473_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","author":"X Castellsagu\u00e9","year":"2003","unstructured":"Castellsagu\u00e9 X, Mu\u00f1oz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis\u2013role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr (31):20\u201328. https:\/\/doi.org\/10.1093\/oxfordjournals.jncimonographs.a003477","journal-title":"J Natl Cancer Inst Monogr"},{"key":"6473_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/ijc.21493","volume":"118","author":"P Appleby","year":"2006","unstructured":"Appleby P et al (2006) Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 118:1481\u20131495","journal-title":"Int J Cancer"},{"key":"6473_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ijc.20970","volume":"116","author":"I Silins","year":"2005","unstructured":"Silins I et al (2005) Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 116:110\u2013115","journal-title":"Int J Cancer"},{"key":"6473_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.285.1.47","volume":"285","author":"T Anttila","year":"2001","unstructured":"Anttila T et al (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285:47\u201351","journal-title":"JAMA"},{"key":"6473_CR36","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1158\/1055-9965.EPI-11-0761","volume":"20","author":"L Arnheim Dahlstr\u00f6m","year":"2011","unstructured":"Arnheim Dahlstr\u00f6m L et al (2011) Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev 20:2541\u20132550","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6473_CR37","doi-asserted-by":"publisher","first-page":"16865","DOI":"10.1038\/srep16865","volume":"5","author":"A Mitra","year":"2015","unstructured":"Mitra A et al (2015) Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep 5:16865","journal-title":"Sci Rep"},{"key":"6473_CR38","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W (2024) Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell 42:946\u2013967","journal-title":"Cancer Cell"},{"key":"6473_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041334","author":"KA Roszkowska","year":"2020","unstructured":"Roszkowska KA, Gizinski S, Sady M, Gajewski Z, Olszewski MB (2020) Gain-of-function mutations in p53 in cancer invasiveness and metastasis. Int J Mol Sci 21(4):1334. https:\/\/doi.org\/10.3390\/ijms21041334","journal-title":"Int J Mol Sci"},{"key":"6473_CR40","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129\u20131136","journal-title":"Cell"},{"key":"6473_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature16481","volume":"529","author":"D Martinez-Zapien","year":"2016","unstructured":"Martinez-Zapien D et al (2016) Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53. Nature 529:541\u2013545","journal-title":"Nature"},{"key":"6473_CR42","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/sj.onc.1202953","volume":"18","author":"M Thomas","year":"1999","unstructured":"Thomas M, Pim D, Banks L (1999) The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18:7690\u20137700","journal-title":"Oncogene"},{"key":"6473_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275\u2013283","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6473_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/1541-7786.MCR-13-0350","volume":"12","author":"KM LaPak","year":"2014","unstructured":"LaPak KM, Burd CE (2014) The molecular balancing act of p16(INK4a) in cancer and aging. Mol Cancer Res 12:167\u2013183","journal-title":"Mol Cancer Res"},{"key":"6473_CR45","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/ijc.28900","volume":"136","author":"C Bergeron","year":"2015","unstructured":"Bergeron C et al (2015) The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments. Int J Cancer 136:2741\u20132751","journal-title":"Int J Cancer"},{"key":"6473_CR46","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/modpathol.3800551","volume":"19","author":"M Benevolo","year":"2006","unstructured":"Benevolo M et al (2006) Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 19:384\u2013391","journal-title":"Mod Pathol"},{"key":"6473_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/01.pap.0000201828.92719.f3","volume":"13","author":"CJ O\u2019Neill","year":"2006","unstructured":"O\u2019Neill CJ, McCluggage WG (2006) p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 13:8\u201315","journal-title":"Adv Anat Pathol"},{"issue":"Suppl 1","key":"6473_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/rmv.1823","volume":"25","author":"J Chen","year":"2015","unstructured":"Chen J (2015) Signaling pathways in HPV-associated cancers and therapeutic implications. Rev Med Virol 25(Suppl 1):24\u201353","journal-title":"Rev Med Virol"},{"key":"6473_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1359-6101(00)00023-X","volume":"12","author":"AE Koromilas","year":"2001","unstructured":"Koromilas AE, Li S, Matlashewski G (2001) Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev 12:157\u2013170","journal-title":"Cytokine Growth Factor Rev"},{"key":"6473_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010373","author":"IT \u00d8vestad","year":"2021","unstructured":"\u00d8vestad IT et al (2021) High-grade cervical intraepithelial neoplasia (CIN) associates with increased proliferation and attenuated immune signaling. Int J Mol Sci 23(1):373. https:\/\/doi.org\/10.3390\/ijms23010373","journal-title":"Int J Mol Sci"},{"key":"6473_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wu J, Ling MT, Zhao L, Zhao K-N (2015) The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer 14:87","journal-title":"Mol Cancer"},{"key":"6473_CR52","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y et al (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6:425","journal-title":"Signal Transduct Target Ther"},{"key":"6473_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA et al (2017) The PI3K Pathway in Human Disease. Cell 170:605\u2013635","journal-title":"Cell"},{"key":"6473_CR54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.virol.2013.04.026","volume":"445","author":"SB Vande Pol","year":"2013","unstructured":"Vande Pol SB, Klingelhutz AJ (2013) Papillomavirus E6 oncoproteins. Virology 445:115\u2013137","journal-title":"Virology"},{"key":"6473_CR55","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","volume":"445","author":"A Roman","year":"2013","unstructured":"Roman A, Munger K (2013) The papillomavirus E7 proteins. Virology 445:138\u2013168","journal-title":"Virology"},{"key":"6473_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","volume":"445","author":"D DiMaio","year":"2013","unstructured":"DiMaio D, Petti LM (2013) The E5 proteins. Virology 445:99\u2013114","journal-title":"Virology"},{"key":"6473_CR57","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/0008-5472.CAN-07-3049","volume":"68","author":"AB Mart\u00ednez-Cruz","year":"2008","unstructured":"Mart\u00ednez-Cruz AB et al (2008) Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors. Cancer Res 68:683\u2013692","journal-title":"Cancer Res"},{"key":"6473_CR58","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/jvi.65.5.2739-2744.1991","volume":"65","author":"H Romanczuk","year":"1991","unstructured":"Romanczuk H, Villa LL, Schlegel R, Howley PM (1991) The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J Virol 65:2739\u20132744","journal-title":"J Virol"},{"key":"6473_CR59","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/sj.onc.1201155","volume":"14","author":"T Nakamura","year":"1997","unstructured":"Nakamura T, Williams-Simons L, Westphal H (1997) A human papillomavirus type 18 E6\/E7 transgene sensitizes mouse lens cells to human wild-type p53-mediated apoptosis. Oncogene 14:2991\u20132998","journal-title":"Oncogene"},{"key":"6473_CR60","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1158\/1078-0432.CCR-06-2704","volume":"13","author":"X Tang","year":"2007","unstructured":"Tang X et al (2007) Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res 13:2568\u20132576","journal-title":"Clin Cancer Res"},{"key":"6473_CR61","doi-asserted-by":"publisher","first-page":"10999","DOI":"10.1128\/JVI.00160-11","volume":"85","author":"PL Hyland","year":"2011","unstructured":"Hyland PL et al (2011) Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6\/E7-expressing keratinocytes. J Virol 85:10999\u201311006","journal-title":"J Virol"},{"key":"6473_CR62","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00018-005-5561-x","volume":"63","author":"S-H Kim","year":"2006","unstructured":"Kim S-H et al (2006) Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK\/ ERK1,2 and PI3K\/Akt. Cell. Mol Life Sci 63:930\u2013938","journal-title":"Mol Life Sci"},{"key":"6473_CR63","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.molonc.2013.03.004","volume":"7","author":"SB Keysar","year":"2013","unstructured":"Keysar SB et al (2013) A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol 7:776\u2013790","journal-title":"Mol Oncol"},{"key":"6473_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/gm453","volume":"5","author":"M Lechner","year":"2013","unstructured":"Lechner M et al (2013) Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV\u2009+\u2009and HPV- tumors. Genome Med 5:49","journal-title":"Genome Med"},{"key":"6473_CR65","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.2174\/0929867321666140414101528","volume":"21","author":"J Wu","year":"2014","unstructured":"Wu J, Chen J, Zhang L, Masci PP, Zhao K-N (2014) Four major factors regulate phosphatidylinositol 3-kinase signaling pathway in cancers induced by infection of human papillomaviruses. Curr Med Chem 21:3057\u20133069","journal-title":"Curr Med Chem"},{"key":"6473_CR66","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.oraloncology.2012.04.013","volume":"48","author":"HS Won","year":"2012","unstructured":"Won HS et al (2012) Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma. Oral Oncol 48:985\u2013990","journal-title":"Oral Oncol"},{"key":"6473_CR67","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1158\/1535-7163.MCT-05-0504","volume":"5","author":"DC Birle","year":"2006","unstructured":"Birle DC, Hedley DW (2006) Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts. Mol Cancer Ther 5:2494\u20132502","journal-title":"Mol Cancer Ther"},{"key":"6473_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08960-2","author":"Y Zhou","year":"2026","unstructured":"Zhou Y et al (2026) Integrated multi-omics profiling of treatment-naive cervix uteri premalignant lesions and cervical squamous cell carcinoma reveals ecosystem and drivers underlying cervical cancer progression. Cell Death Dis 17(1):722. https:\/\/doi.org\/10.1038\/s41419-026-08960-2","journal-title":"Cell Death Dis"},{"key":"6473_CR69","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4143\/crt.2006.38.2.112","volume":"38","author":"JK Park","year":"2006","unstructured":"Park JK et al (2006) Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3-kinase inhibition in the human cervical cancer cell-line. Cancer Res Treat 38:112\u2013117","journal-title":"Cancer Res Treat"},{"key":"6473_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-469-2_1","volume":"469","author":"JC Croce","year":"2008","unstructured":"Croce JC, McClay DR (2008) Evolution of the Wnt pathways. Methods Mol Biol 469:3\u201318","journal-title":"Methods Mol Biol"},{"key":"6473_CR71","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2353\/ajpath.2010.091125","volume":"176","author":"AI Khramtsov","year":"2010","unstructured":"Khramtsov AI et al (2010) Wnt\/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 176:2911\u20132920","journal-title":"Am J Pathol"},{"key":"6473_CR72","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/eji.200738118","volume":"38","author":"FJT Staal","year":"2008","unstructured":"Staal FJT, Sen JM (2008) The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis. Eur J Immunol 38:1788\u20131794","journal-title":"Eur J Immunol"},{"key":"6473_CR73","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbrc.2010.01.028","volume":"392","author":"Y Teng","year":"2010","unstructured":"Teng Y, Wang X, Wang Y, Ma D (2010) Wnt\/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun 392:373\u2013379","journal-title":"Biochem Biophys Res Commun"},{"key":"6473_CR74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbamcr.2015.11.020","volume":"1863","author":"T Borggrefe","year":"2016","unstructured":"Borggrefe T et al (2016) The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGF\u03b2\/BMP and hypoxia pathways. Biochim Biophys Acta 1863:303\u2013313","journal-title":"Biochim Biophys Acta"},{"key":"6473_CR75","doi-asserted-by":"publisher","first-page":"36814","DOI":"10.1074\/jbc.M112.356048","volume":"287","author":"E-J Ann","year":"2012","unstructured":"Ann E-J et al (2012) Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. J Biol Chem 287:36814\u201336829","journal-title":"J Biol Chem"},{"key":"6473_CR76","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1007\/s00018-014-1644-x","volume":"71","author":"GM Collu","year":"2014","unstructured":"Collu GM, Hidalgo-Sastre A, Brennan K (2014) Wnt-Notch signalling crosstalk in development and disease. Cell Mol Life Sci 71:3553\u20133567","journal-title":"Cell Mol Life Sci"},{"key":"6473_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11010-017-3216-5","volume":"443","author":"C Chakraborty","year":"2018","unstructured":"Chakraborty C et al (2018) Activation of Wnt-\u03b2-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma. Mol Cell Biochem 443:121\u2013130","journal-title":"Mol Cell Biochem"},{"key":"6473_CR78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1158\/1541-7786.MCR-09-0345","volume":"8","author":"T Rampias","year":"2010","unstructured":"Rampias T et al (2010) Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res 8:433\u2013443","journal-title":"Mol Cancer Res"},{"key":"6473_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.virol.2009.10.011","volume":"396","author":"H Lichtig","year":"2010","unstructured":"Lichtig H et al (2010) HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology 396:47\u201358","journal-title":"Virology"},{"key":"6473_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1476-5586(04)80048-4","volume":"6","author":"B He","year":"2004","unstructured":"He B et al (2004) A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6:7\u201314","journal-title":"Neoplasia"},{"key":"6473_CR81","first-page":"60","volume":"21","author":"WA Messersmith","year":"2015","unstructured":"Messersmith WA et al (2015) A Phase I, dose-finding study in patients with advanced solid malignancies of the oral \u03b3-secretase inhibitor PF-03084014. Clin. Cancer Res 21:60\u201367","journal-title":"Cancer Res"},{"key":"6473_CR82","doi-asserted-by":"publisher","unstructured":"Gounder MM (2015) Notch inhibition in desmoids: \u2018Sure it works in practice, but does it work in theory?\u2019. Cancer vol. 121 3933\u20133937 Preprint at https:\/\/doi.org\/10.1002\/cncr.29562","DOI":"10.1002\/cncr.29562"},{"key":"6473_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2407-5-53","volume":"5","author":"I Mikami","year":"2005","unstructured":"Mikami I et al (2005) Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. BMC Cancer 5:53","journal-title":"BMC Cancer"},{"key":"6473_CR84","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu J et al (2013) Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A 110:20224\u201320229","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6473_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.540332","volume":"10","author":"Y Wu","year":"2020","unstructured":"Wu Y et al (2020) ST3Gal IV mediates the growth and proliferation of cervical cancer cells in vitro and in vivo via the Notch\/p21\/CDKs pathway. Front Oncol 10:540332","journal-title":"Front Oncol"},{"key":"6473_CR86","doi-asserted-by":"publisher","first-page":"18093","DOI":"10.1007\/s00432-023-05495-3","volume":"149","author":"W Li","year":"2023","unstructured":"Li W et al (2023) Jagged1 contained in MSC-derived small extracellular vesicles promotes squamous differentiation of cervical cancer by activating NOTCH pathway. J Cancer Res Clin Oncol 149:18093\u201318102","journal-title":"J Cancer Res Clin Oncol"},{"key":"6473_CR87","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1007\/s43032-021-00626-y","volume":"28","author":"Q Wu","year":"2021","unstructured":"Wu Q, Lu S, Zhang L, Zhao L (2021) LncRNA HOXA-AS2 Activates the Notch Pathway to Promote Cervical Cancer Cell Proliferation and Migration. Reprod Sci 28:3000\u20133009","journal-title":"Reprod Sci"},{"key":"6473_CR88","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/1440-1681.13123","volume":"46","author":"L Ma","year":"2019","unstructured":"Ma L, Cheng Y, Zeng J (2019) MLK3 silence induces cervical cancer cell apoptosis via the Notch-1\/autophagy network. Clin Exp Pharmacol Physiol 46:854\u2013860","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"6473_CR89","doi-asserted-by":"crossref","unstructured":"Dayer G, Masoom ML, Togtema M, Zehbe I (2020) Virus-Host Protein-Protein Interactions between Human Papillomavirus 16 E6 A1 and D2\/D3 Sub-Lineages: Variances and Similarities. Int J Mol Sci 21(21):7980","DOI":"10.3390\/ijms21217980"},{"key":"6473_CR90","first-page":"10","volume":"6","author":"Y-H Huang","year":"2021","unstructured":"Huang Y-H et al (2021) CREBBP\/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2\/CSF1 axis. Signal Transduct. Target Ther 6:10","journal-title":"Target Ther"},{"key":"6473_CR91","doi-asserted-by":"publisher","first-page":"190187","DOI":"10.1098\/rsob.190187","volume":"9","author":"JD Brandstadter","year":"2019","unstructured":"Brandstadter JD, Maillard I (2019) Notch signalling in T cell homeostasis and differentiation. Open Biol 9:190187","journal-title":"Open Biol"},{"key":"6473_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713660","author":"Q Mei","year":"2023","unstructured":"Mei Q, Xu X, Gao D, Xu Y, Yang J (2023) Inhibition of Notch signaling enhances antitumor activity of histone deacetylase inhibitor LAQ824. Int J Mol Sci 24(17):13660. https:\/\/doi.org\/10.3390\/ijms241713660","journal-title":"Int J Mol Sci"},{"key":"6473_CR93","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181377","author":"J-Y Wang","year":"2019","unstructured":"Wang J-Y, Chen L-J (2019) The role of miRNAs in the invasion and metastasis of cervical cancer. Biosci Rep 39(3):BSR20181377. https:\/\/doi.org\/10.1042\/BSR20181377","journal-title":"Biosci Rep"},{"key":"6473_CR94","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/bjc.2014.497","volume":"111","author":"I Brana","year":"2014","unstructured":"Brana I et al (2014) A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours. Br J Cancer 111:1932\u20131944","journal-title":"Br J Cancer"},{"key":"6473_CR95","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/bjc.2017.495","volume":"118","author":"N Cook","year":"2018","unstructured":"Cook N et al (2018) A phase I trial of the \u03b3-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer 118:793\u2013801","journal-title":"Br J Cancer"},{"key":"6473_CR96","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1200\/JCO.2011.39.1540","volume":"30","author":"I Krop","year":"2012","unstructured":"Krop I et al (2012) Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol 30:2307\u20132313","journal-title":"J Clin Oncol"},{"key":"6473_CR97","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/sj.onc.1206043","volume":"22","author":"A Nair","year":"2003","unstructured":"Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D (2003) NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22:50\u201358","journal-title":"Oncogene"},{"key":"6473_CR98","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1016\/j.csbj.2021.11.034","volume":"19","author":"F Cossu","year":"2021","unstructured":"Cossu F et al (2021) Structure-based identification of a new IAP-targeting compound that induces cancer cell death inducing NF-\u03baB pathway. Comput Struct Biotechnol J 19:6366\u20136374","journal-title":"Comput Struct Biotechnol J"},{"key":"6473_CR99","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41374-021-00544-2","volume":"101","author":"X Wang","year":"2021","unstructured":"Wang X et al (2021) IL-37b\u22061\u201345 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1\/NF-\u03baB\/MMP2 signal pathway. Lab Invest 101:760\u2013774","journal-title":"Lab Invest"},{"key":"6473_CR100","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1002\/jcp.30759","volume":"237","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S et al (2022) NF-\u03baB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J Cell Physiol 237:2770\u20132795","journal-title":"J Cell Physiol"},{"key":"6473_CR101","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2011.12.023","volume":"425","author":"ER Vandermark","year":"2012","unstructured":"Vandermark ER et al (2012) Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. Virology 425:53\u201360","journal-title":"Virology"},{"key":"6473_CR102","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00404-008-0667-7","volume":"279","author":"S Kamer","year":"2009","unstructured":"Kamer S, Ren Q, Dicker AP (2009) Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341). Arch Gynecol Obstet 279:41\u201346","journal-title":"Arch Gynecol Obstet"},{"key":"6473_CR103","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bcp.2009.12.021","volume":"79","author":"SC Miller","year":"2010","unstructured":"Miller SC et al (2010) Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action. Biochem Pharmacol 79:1272\u20131280","journal-title":"Biochem Pharmacol"},{"key":"6473_CR104","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","volume":"6","author":"JY Fang","year":"2005","unstructured":"Fang JY, Richardson BC (2005) The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6:322\u2013327","journal-title":"Lancet Oncol"},{"key":"6473_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114412","volume":"280","author":"JW Kim","year":"2021","unstructured":"Kim JW et al (2021) Anti-cancer effects of the aqueous extract of Orostachys japonica A. Berger on 5-fluorouracil-resistant colorectal cancer via MAPK signalling pathways in vitro and in vivo. J Ethnopharmacol 280:114412","journal-title":"J Ethnopharmacol"},{"key":"6473_CR106","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1128\/JVI.76.1.220-231.2002","volume":"76","author":"B Zhang","year":"2002","unstructured":"Zhang B, Spandau DF, Roman A (2002) E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. J Virol 76:220\u2013231","journal-title":"J Virol"},{"key":"6473_CR107","doi-asserted-by":"publisher","first-page":"e29315","DOI":"10.1002\/jmv.29315","volume":"95","author":"J Skelin","year":"2023","unstructured":"Skelin J, Luk HY, Butorac D, Boon SS, Tomai\u0107 V (2023) The effects of HPV oncoproteins on host communication networks: Therapeutic connotations. J Med Virol 95:e29315","journal-title":"J Med Virol"},{"key":"6473_CR108","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1002\/jcp.29452","volume":"235","author":"N Dong","year":"2020","unstructured":"Dong N et al (2020) Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-\u03baB\/MAPK signaling pathway. J Cell Physiol 235:5525\u20135540","journal-title":"J Cell Physiol"},{"key":"6473_CR109","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s10787-022-01075-y","volume":"30","author":"S-M Kim","year":"2022","unstructured":"Kim S-M, Park E-J, Lee H-J (2022) Nuciferine attenuates lipopolysaccharide-stimulated inflammatory responses by inhibiting p38 MAPK\/ATF2 signaling pathways. Inflammopharmacology 30:2373\u20132383","journal-title":"Inflammopharmacology"},{"key":"6473_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311168","author":"KD Lynch","year":"2023","unstructured":"Lynch KD et al (2023) Involvement of the p38\/MK2 pathway in MCLR hepatotoxicity revealed through MAPK pharmacological inhibition and phosphoproteomics in HepaRG cells. Int J Mol Sci 24(13):11168. https:\/\/doi.org\/10.3390\/ijms241311168","journal-title":"Int J Mol Sci"},{"key":"6473_CR111","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.neo.2021.05.009","volume":"23","author":"VC Mak","year":"2021","unstructured":"Mak VC et al (2021) p85\u03b2 alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair. Neoplasia 23:718\u2013730","journal-title":"Neoplasia"},{"key":"6473_CR112","doi-asserted-by":"publisher","first-page":"102447","DOI":"10.1016\/j.eclinm.2024.102447","volume":"69","author":"T Shimoi","year":"2024","unstructured":"Shimoi T et al (2024) Dabrafenib and trametinib administration in patients with BRAF V600E\/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial. EClinicalMedicine 69:102447","journal-title":"EClinicalMedicine"},{"key":"6473_CR113","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(21)02175-9","volume":"399","author":"DM Gershenson","year":"2022","unstructured":"Gershenson DM et al (2022) Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281\/LOGS): an international, randomised, open-label, multicentre, phase 2\/3 trial. Lancet 399:541\u2013553","journal-title":"Lancet"},{"key":"6473_CR114","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.matbio.2023.11.001","volume":"125","author":"S Fernandes","year":"2024","unstructured":"Fernandes S et al (2024) TGF-\u03b2 induces matrisome pathological alterations and EMT in patient-derived prostate cancer tumoroids. Matrix Biol 125:12\u201330","journal-title":"Matrix Biol"},{"key":"6473_CR115","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","volume":"577","author":"J Su","year":"2020","unstructured":"Su J et al (2020) TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature 577:566\u2013571","journal-title":"Nature"},{"key":"6473_CR116","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z et al (2024) TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther 9:61","journal-title":"Signal Transduct Target Ther"},{"key":"6473_CR117","doi-asserted-by":"publisher","first-page":"38557","DOI":"10.1074\/jbc.M206786200","volume":"277","author":"DK Lee","year":"2002","unstructured":"Lee DK et al (2002) The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence. J Biol Chem 277:38557\u201338564","journal-title":"J Biol Chem"},{"key":"6473_CR118","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2005.09.006","volume":"17","author":"B Bierie","year":"2006","unstructured":"Bierie B, Moses HL (2006) TGF-beta and cancer. Cytokine Growth Factor Rev 17:29\u201340","journal-title":"Cytokine Growth Factor Rev"},{"key":"6473_CR119","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trsl.2022.04.003","volume":"247","author":"JW Chang","year":"2022","unstructured":"Chang JW et al (2022) Claudin-1 mediates progression by regulating EMT through AMPK\/TGF-\u03b2 signaling in head and neck squamous cell carcinoma. Transl Res 247:58\u201378","journal-title":"Transl Res"},{"key":"6473_CR120","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abo2206","volume":"15","author":"Z Ye","year":"2022","unstructured":"Ye Z et al (2022) Characterization of TGF-\u03b2 signaling in a human organotypic skin model reveals that loss of TGF-\u03b2RII induces invasive tissue growth. Sci Signal 15:eabo2206","journal-title":"Sci Signal"},{"key":"6473_CR121","doi-asserted-by":"publisher","first-page":"115355","DOI":"10.1016\/j.biopha.2023.115355","volume":"166","author":"S Yin","year":"2023","unstructured":"Yin S, Cui H, Qin S, Yu S (2023) Manipulating TGF-\u03b2 signaling to optimize immunotherapy for cervical cancer. Biomed Pharmacother 166:115355","journal-title":"Biomed Pharmacother"},{"key":"6473_CR122","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004122","author":"Y Lan","year":"2022","unstructured":"Lan Y et al (2022) Colocalized targeting of TGF-\u03b2 and PD-L1 by bintrafusp alfa elicits distinct antitumor responses. J Immunother Cancer 10(7):e004122. https:\/\/doi.org\/10.1136\/jitc-2021-004122","journal-title":"J Immunother Cancer"},{"key":"6473_CR123","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao X, Wan YY (2023) Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology. Cell Mol Immunol 20:1002\u20131022","journal-title":"Cell Mol Immunol"},{"key":"6473_CR124","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fimmu.2020.00311","volume":"11","author":"S Regis","year":"2020","unstructured":"Regis S, Dondero A, Caliendo F, Bottino C, Castriconi R (2020) NK Cell Function Regulation by TGF-\u03b2-Induced Epigenetic Mechanisms. Front Immunol 11:311","journal-title":"Front Immunol"},{"key":"6473_CR125","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S1470-2045(22)00446-6","volume":"23","author":"T Yamazaki","year":"2022","unstructured":"Yamazaki T et al (2022) Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial. Lancet Oncol 23:1189\u20131200","journal-title":"Lancet Oncol"},{"key":"6473_CR126","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000056","volume":"10","author":"RK Kelley","year":"2019","unstructured":"Kelley RK et al (2019) A phase 2 study of galunisertib (TGF-\u03b21 receptor type I inhibitor) and sorafenib in patients with advanced hepatocellular carcinoma. Clin Transl Gastroenterol 10:e00056","journal-title":"Clin Transl Gastroenterol"},{"key":"6473_CR127","doi-asserted-by":"publisher","first-page":"117483","DOI":"10.1016\/j.biopha.2024.117483","volume":"180","author":"H Wang","year":"2024","unstructured":"Wang H et al (2024) Research advances in signaling pathways related to the malignant progression of HSIL to invasive cervical cancer: A review. Biomed Pharmacother 180:117483","journal-title":"Biomed Pharmacother"},{"key":"6473_CR128","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ygyno.2017.02.040","volume":"145","author":"JS Rader","year":"2017","unstructured":"Rader JS et al (2017) A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology\/Gynecologic Oncology Group study. Gynecol Oncol 145:291\u2013297","journal-title":"Gynecol Oncol"},{"key":"6473_CR129","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309\u2013322","journal-title":"Cancer Cell"},{"key":"6473_CR130","doi-asserted-by":"publisher","first-page":"107101","DOI":"10.1016\/j.intimp.2020.107101","volume":"89","author":"H Zhao","year":"2020","unstructured":"Zhao H, Wei J, Sun J (2020) Roles of TGF-\u03b2 signaling pathway in tumor microenvirionment and cancer therapy. Int Immunopharmacol 89:107101","journal-title":"Int Immunopharmacol"},{"key":"6473_CR131","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/ijc.28309","volume":"133","author":"PJ de Vos","year":"2013","unstructured":"de Vos PJ et al (2013) Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma. Int J Cancer 133:2884\u20132894","journal-title":"Int J Cancer"},{"key":"6473_CR132","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.tcb.2014.11.001","volume":"25","author":"C Hagerling","year":"2015","unstructured":"Hagerling C, Casbon A-J, Werb Z (2015) Balancing the innate immune system in tumor development. Trends Cell Biol 25:214\u2013220","journal-title":"Trends Cell Biol"},{"key":"6473_CR133","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.7150\/jca.21444","volume":"8","author":"X-J Chen","year":"2017","unstructured":"Chen X-J et al (2017) Clinical Significance of CD163\u2009+\u2009and CD68\u2009+\u2009Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer. J Cancer 8:3868\u20133875","journal-title":"J Cancer"},{"key":"6473_CR134","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ygyno.2006.11.023","volume":"105","author":"LS Hammes","year":"2007","unstructured":"Hammes LS et al (2007) Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression\u2013clinicopathological correlation. Gynecol Oncol 105:157\u2013165","journal-title":"Gynecol Oncol"},{"key":"6473_CR135","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605\u2013612","journal-title":"Cancer Res"},{"key":"6473_CR136","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/ijc.29389","volume":"137","author":"S Demoulin","year":"2015","unstructured":"Demoulin S et al (2015) HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells. Int J Cancer 137:345\u2013358","journal-title":"Int J Cancer"},{"key":"6473_CR137","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41416-020-01184-x","volume":"124","author":"TR Litwin","year":"2021","unstructured":"Litwin TR et al (2021) Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis. Br J Cancer 124:831\u2013841","journal-title":"Br J Cancer"},{"key":"6473_CR138","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","volume":"23","author":"IT \u00d8vestad","year":"2010","unstructured":"\u00d8vestad IT et al (2010) Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression. Mod Pathol 23:1231\u20131240","journal-title":"Mod Pathol"},{"key":"6473_CR139","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJLM, Shah K (2002) V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244\u2013265","journal-title":"J Clin Pathol"},{"key":"6473_CR140","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","volume":"24","author":"MO Li","year":"2006","unstructured":"Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99\u2013146","journal-title":"Annu Rev Immunol"},{"key":"6473_CR141","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/erv.12.56","volume":"11","author":"EMG van Esch","year":"2012","unstructured":"van Esch EMG et al (2012) Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy. Expert Rev Vaccines 11:821\u2013840","journal-title":"Expert Rev Vaccines"},{"key":"6473_CR142","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/cam4.3833","volume":"10","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) The immune landscape during the tumorigenesis of cervical cancer. Cancer Med 10:2380\u20132395","journal-title":"Cancer Med"},{"key":"6473_CR143","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/imm.12101","volume":"139","author":"W Yang","year":"2013","unstructured":"Yang W, Song Y, Lu Y-L, Sun J-Z, Wang H-W (2013) Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia. Immunology 139:513\u2013522","journal-title":"Immunology"},{"key":"6473_CR144","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan ZE et al (2019) Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine 44:675\u2013690","journal-title":"EBioMedicine"},{"key":"6473_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137174","author":"B Gardella","year":"2022","unstructured":"Gardella B et al (2022) The complex interplay between vaginal microbiota, HPV infection, and immunological microenvironment in cervical intraepithelial neoplasia: a literature review. Int J Mol Sci 23(13):7174. https:\/\/doi.org\/10.3390\/ijms23137174","journal-title":"Int J Mol Sci"},{"key":"6473_CR146","doi-asserted-by":"publisher","first-page":"e1008376","DOI":"10.1371\/journal.ppat.1008376","volume":"16","author":"M Usyk","year":"2020","unstructured":"Usyk M et al (2020) Cervicovaginal microbiome and natural history of HPV in a longitudinal study. PLoS Pathog 16:e1008376","journal-title":"PLoS Pathog"},{"key":"6473_CR147","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41467-020-15856-y","volume":"11","author":"A Mitra","year":"2020","unstructured":"Mitra A et al (2020) The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions. Nat Commun 11:1999","journal-title":"Nat Commun"},{"key":"6473_CR148","doi-asserted-by":"crossref","unstructured":"Jayshree RS (2021) The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator. Front Cell Infect Microbiol 11:649815","DOI":"10.3389\/fcimb.2021.649815"},{"key":"6473_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11030662","author":"C Gargiulo Isacco","year":"2023","unstructured":"Gargiulo Isacco C et al (2023) Alterations of vaginal microbiota and Chlamydia trachomatis as crucial co-causative factors in cervical cancer genesis procured by HPV. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms11030662","journal-title":"Microorganisms"},{"key":"6473_CR150","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ng.3178","volume":"47","author":"Z Hu","year":"2015","unstructured":"Hu Z et al (2015) Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet 47:158\u2013163","journal-title":"Nat Genet"},{"key":"6473_CR151","doi-asserted-by":"publisher","unstructured":"Sundstr\u00f6m K, Elfstr\u00f6m KM (2020) Advances in cervical cancer prevention: Efficacy, effectiveness, elimination? PLoS medicine vol. 17 e1003035 Preprint at https:\/\/doi.org\/10.1371\/journal.pmed.1003035","DOI":"10.1371\/journal.pmed.1003035"},{"key":"6473_CR152","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.hoc.2024.03.005","volume":"38","author":"VV Sahasrabuddhe","year":"2024","unstructured":"Sahasrabuddhe VV (2024) Cervical Cancer: Precursors and Prevention. Hematol Oncol Clin North Am 38:771\u2013781","journal-title":"Hematol Oncol Clin North Am"},{"key":"6473_CR153","first-page":"300","volume":"64","author":"E Petrosky","year":"2015","unstructured":"Petrosky E et al (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 64:300\u2013304","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"6473_CR154","doi-asserted-by":"publisher","first-page":"e20151968","DOI":"10.1542\/peds.2015-1968","volume":"137","author":"LE Markowitz","year":"2016","unstructured":"Markowitz LE et al (2016) Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 137:e20151968. https:\/\/doi.org\/10.1542\/peds.2015-1968","journal-title":"Pediatrics"},{"key":"6473_CR155","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/ijpvm.IJPVM_413_16","volume":"8","author":"MR Haghshenas","year":"2017","unstructured":"Haghshenas MR, Mousavi T, Kheradmand M, Afshari M, Moosazadeh M (2017) Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial Neoplasia: A Meta-analysis. Int J Prev Med 8:44","journal-title":"Int J Prev Med"},{"key":"6473_CR156","doi-asserted-by":"publisher","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","volume":"17","author":"KA Szymonowicz","year":"2020","unstructured":"Szymonowicz KA, Chen J (2020) Biological and clinical aspects of HPV-related cancers. Cancer Biol Med 17:864\u2013878","journal-title":"Cancer Biol Med"},{"key":"6473_CR157","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41417-023-00682-3","volume":"31","author":"Q Peng","year":"2024","unstructured":"Peng Q et al (2024) HPV E6\/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor. Cancer Gene Ther 31:9\u201317","journal-title":"Cancer Gene Ther"},{"key":"6473_CR158","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1017\/S0950268817000747","volume":"145","author":"C Signorelli","year":"2017","unstructured":"Signorelli C et al (2017) Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence. Epidemiol Infect 145:1962\u20131982","journal-title":"Epidemiol Infect"},{"key":"6473_CR159","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pop.2018.10.011","volume":"46","author":"SE Stumbar","year":"2019","unstructured":"Stumbar SE, Stevens M, Feld Z (2019) Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management. Prim Care 46:117\u2013134","journal-title":"Prim Care"},{"key":"6473_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2024.102522","volume":"96","author":"E Miyagi","year":"2024","unstructured":"Miyagi E, Mizushima T (2024) Is there a need for screening of cervical HPV infections and carcinoma? Best Pract Res Clin Obstet Gynaecol 96:102522","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"6473_CR161","doi-asserted-by":"publisher","unstructured":"Voelker RA (2023) Cervical Cancer Screening. JAMA vol. 330 2030 Preprint at https:\/\/doi.org\/10.1001\/jama.2023.21987","DOI":"10.1001\/jama.2023.21987"},{"key":"6473_CR162","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1001\/jama.2019.4595","volume":"321","author":"GF Sawaya","year":"2019","unstructured":"Sawaya GF, Smith-McCune K, Kuppermann M (2019) Cervical Cancer Screening: More Choices in 2019. JAMA 321:2018\u20132019","journal-title":"JAMA"},{"key":"6473_CR163","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1001\/jama.2009.1569","volume":"302","author":"AG Siebers","year":"2009","unstructured":"Siebers AG et al (2009) Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA 302:1757\u20131764","journal-title":"JAMA"},{"key":"6473_CR164","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/ijgc-2022-004197","volume":"33","author":"K Cuschieri","year":"2023","unstructured":"Cuschieri K et al (2023) Quality assurance in human papillomavirus testing for primary cervical screening. Int J Gynecol Cancer 33:802\u2013811","journal-title":"Int J Gynecol Cancer"},{"key":"6473_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01613-x","volume":"18","author":"P Xue","year":"2020","unstructured":"Xue P, Ng MTA, Qiao Y (2020) The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence. BMC Med 18:169","journal-title":"BMC Med"},{"key":"6473_CR166","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/ijgc-2022-003703","volume":"33","author":"D Viveros-Carre\u00f1o","year":"2023","unstructured":"Viveros-Carre\u00f1o D, Fernandes A, Pareja R (2023) Updates on cervical cancer prevention. Int J Gynecol Cancer 33:394\u2013402","journal-title":"Int J Gynecol Cancer"},{"key":"6473_CR167","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13148-020-00853-1","volume":"12","author":"L Dong","year":"2020","unstructured":"Dong L et al (2020) Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study. Clin Epigenetics 12:62","journal-title":"Clin Epigenetics"},{"key":"6473_CR168","doi-asserted-by":"publisher","first-page":"831949","DOI":"10.3389\/fonc.2022.831949","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Tan W, Yang H, Zhang S, Dai Y (2022) Detection of Host Cell Gene\/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer. Front Oncol 12:831949","journal-title":"Front Oncol"},{"key":"6473_CR169","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2217\/epi-2022-0160","volume":"14","author":"CR Hillyar","year":"2022","unstructured":"Hillyar CR et al (2022) A systematic review and meta-analysis of the diagnostic effectiveness of human papillomavirus methylation biomarkers for detection of cervical cancer. Epigenomics 14:1055\u20131072","journal-title":"Epigenomics"},{"key":"6473_CR170","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.currproblcancer.2018.01.010","volume":"42","author":"P Basu","year":"2018","unstructured":"Basu P, Taghavi K, Hu S-Y, Mogri S, Joshi S (2018) Management of cervical premalignant lesions. Curr Probl Cancer 42:129\u2013136","journal-title":"Curr Probl Cancer"},{"key":"6473_CR171","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(98)00392-4","volume":"353","author":"JT Cox","year":"1999","unstructured":"Cox JT (1999) Management of cervical intraepithelial neoplasia. Lancet 353:857\u2013859","journal-title":"Lancet"},{"key":"6473_CR172","doi-asserted-by":"crossref","unstructured":"Martin-Hirsch PPL, Paraskevaidis E, Bryant A, Dickinson H (2013) O. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev CD001318 (2013)","DOI":"10.1002\/14651858.CD001318.pub3"},{"key":"6473_CR173","doi-asserted-by":"publisher","unstructured":"Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL (2010) Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev CD001318. https:\/\/doi.org\/10.1002\/14651858.CD001318.pub2","DOI":"10.1002\/14651858.CD001318.pub2"},{"key":"6473_CR174","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N et al (2016) World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2\u20133 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet 132:252\u2013258","journal-title":"Int J Gynaecol Obstet"},{"key":"6473_CR175","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/her\/15.6.681","volume":"15","author":"J Shepherd","year":"2000","unstructured":"Shepherd J, Peersman G, Weston R, Napuli I (2000) Cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women. Health Educ Res 15:681\u2013694","journal-title":"Health Educ Res"},{"key":"6473_CR176","doi-asserted-by":"publisher","first-page":"21","DOI":"10.25259\/CMAS_03_02_2021","volume":"19","author":"S Pimple","year":"2022","unstructured":"Pimple S, Mishra G (2022) Cancer cervix: Epidemiology and disease burden. Cytojournal 19:21","journal-title":"Cytojournal"},{"key":"6473_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cncr.22425","volume":"111","author":"D Dehn","year":"2007","unstructured":"Dehn D, Torkko KC, Shroyer KR (2007) Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 111:1\u201314","journal-title":"Cancer"},{"key":"6473_CR178","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"R Klaes","year":"2001","unstructured":"Klaes R et al (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276\u2013284","journal-title":"Int J Cancer"},{"key":"6473_CR179","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/PAT.0000000000000249","volume":"47","author":"SN Tabrizi","year":"2015","unstructured":"Tabrizi SN et al (2015) Evaluation of p16INK4a immunostaining for the detection of high-grade changes in cervical cytology. Pathology 47:314\u2013319","journal-title":"Pathology"},{"key":"6473_CR180","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","volume":"26","author":"R Klaes","year":"2002","unstructured":"Klaes R et al (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26:1389\u20131399","journal-title":"Am J Surg Pathol"},{"key":"6473_CR181","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jcp.56.1.56","volume":"56","author":"N Murphy","year":"2003","unstructured":"Murphy N et al (2003) p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 56:56\u201363","journal-title":"J Clin Pathol"},{"key":"6473_CR182","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00203-023-03736-0","volume":"206","author":"M Shafique","year":"2023","unstructured":"Shafique M et al (2023) Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker. Arch Microbiol 206:17","journal-title":"Arch Microbiol"},{"key":"6473_CR183","first-page":"3201","volume":"17","author":"K Kanthiya","year":"2016","unstructured":"Kanthiya K, Khunnarong J, Tangjitgamol S, Puripat N, Tanvanich S (2016) Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer. Asian Pac J Cancer Prev 17:3201\u20133206","journal-title":"Asian Pac J Cancer Prev"},{"key":"6473_CR184","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11584-z","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Su S, Liu Y (2022) The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL. Sci Rep 12:7613","journal-title":"Sci Rep"},{"key":"6473_CR185","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1590\/0100-69912017002005","volume":"44","author":"APS Goulart","year":"2017","unstructured":"Goulart APS, Gon\u00e7alves MAG, DA-Silva VD (2017) Evaluation of Telomerase (hTert), Ki67 and p16ink4a expressions in low and high-grade cervical intraepithelial lesions. Rev Col Bras Cir 44:131\u2013139","journal-title":"Rev Col Bras Cir"},{"key":"6473_CR186","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ijc.34686","volume":"154","author":"M El-Zein","year":"2024","unstructured":"El-Zein M, Cheishvili D, Szyf M, Franco EL (2024) Validation of novel DNA methylation markers in cervical precancer and cancer. Int J Cancer 154:104\u2013113","journal-title":"Int J Cancer"},{"key":"6473_CR187","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13148-016-0196-3","volume":"8","author":"A Boers","year":"2016","unstructured":"Boers A et al (2016) Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2\/3. Clin Epigenetics 8:29","journal-title":"Clin Epigenetics"},{"key":"6473_CR188","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2217\/epi-2019-0331","volume":"12","author":"S Dick","year":"2020","unstructured":"Dick S et al (2020) Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer. Epigenomics 12:1569\u20131578","journal-title":"Epigenomics"},{"key":"6473_CR189","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-21-3710","volume":"28","author":"R van den Helder","year":"2022","unstructured":"van den Helder R et al (2022) HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection. Clin Cancer Res 28:2061\u20132068","journal-title":"Clin Cancer Res"},{"key":"6473_CR190","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00125480-200103000-00004","volume":"8","author":"JT Keating","year":"2001","unstructured":"Keating JT, Ince T, Crum CP (2001) Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol 8:83\u201392","journal-title":"Adv Anat Pathol"},{"key":"6473_CR191","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/1055-9965.EPI-06-0540","volume":"16","author":"M Steinau","year":"2007","unstructured":"Steinau M et al (2007) Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells. Cancer Epidemiol Biomarkers Prev 16:295\u2013301","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6473_CR192","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.onc.1205073","volume":"21","author":"EA Jarboe","year":"2002","unstructured":"Jarboe EA et al (2002) Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma. Oncogene 21:664\u2013673","journal-title":"Oncogene"},{"key":"6473_CR193","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1525-1438.2007.00980.x","volume":"17","author":"MI Rosa","year":"2007","unstructured":"Rosa MI et al (2007) Accuracy of telomerase in cervical lesions: a systematic review. Int J Gynecol Cancer 17:1205\u20131214","journal-title":"Int J Gynecol Cancer"},{"key":"6473_CR194","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/carcin\/bgaa046","volume":"41","author":"J Wittenborn","year":"2020","unstructured":"Wittenborn J, Weikert L, Hangarter B, Stickeler E, Maurer J (2020) The use of micro RNA in the early detection of cervical intraepithelial neoplasia. Carcinogenesis 41:1781\u20131789","journal-title":"Carcinogenesis"},{"key":"6473_CR195","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/1878-0261.12383","volume":"12","author":"SS Liu","year":"2018","unstructured":"Liu SS et al (2018) Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer. Mol Oncol 12:2009\u20132022","journal-title":"Mol Oncol"},{"key":"6473_CR196","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ygyno.2003.11.010","volume":"92","author":"AA El-Ghobashy","year":"2004","unstructured":"El-Ghobashy AA et al (2004) Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix. Gynecol Oncol 92:628\u2013634","journal-title":"Gynecol Oncol"},{"key":"6473_CR197","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/modpathol.3800361","volume":"18","author":"N Murphy","year":"2005","unstructured":"Murphy N et al (2005) Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix. Mod Pathol 18:844\u2013849","journal-title":"Mod Pathol"},{"key":"6473_CR198","doi-asserted-by":"publisher","first-page":"pbae016","DOI":"10.1093\/pcmedi\/pbae016","volume":"7","author":"RC Cintra","year":"2024","unstructured":"Cintra RC et al (2024) Computational insights into CRISP3 downregulation in cervical cancer and its cervical lineages pattern. Precis Clin Med 7:pbae016","journal-title":"Precis Clin Med"},{"key":"6473_CR199","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41571-020-00449-x","volume":"18","author":"SH Gohil","year":"2021","unstructured":"Gohil SH, Iorgulescu JB, Braun DA, Keskin DB, Livak KJ (2021) Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy. Nat Rev Clin Oncol 18:244\u2013256","journal-title":"Nat Rev Clin Oncol"},{"key":"6473_CR200","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y et al (2021) Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol 14:91","journal-title":"J Hematol Oncol"},{"key":"6473_CR201","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1038\/s41467-022-33982-7","volume":"13","author":"X Ren","year":"2022","unstructured":"Ren X et al (2022) Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma. Nat Commun 13:6300","journal-title":"Nat Commun"},{"key":"6473_CR202","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/imr.12976","volume":"302","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Swarbrick A (2021) Single-cell advances in stromal-leukocyte interactions in cancer. Immunol Rev 302:286\u2013298","journal-title":"Immunol Rev"},{"key":"6473_CR203","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cell.2019.03.005","volume":"177","author":"J Wagner","year":"2019","unstructured":"Wagner J et al (2019) A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell 177:1330\u20131345e18","journal-title":"Cell"},{"key":"6473_CR204","doi-asserted-by":"publisher","first-page":"109165","DOI":"10.1016\/j.celrep.2021.109165","volume":"35","author":"S Olalekan","year":"2021","unstructured":"Olalekan S, Xie B, Back R, Eckart H, Basu A (2021) Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics. Cell Rep 35:109165","journal-title":"Cell Rep"},{"key":"6473_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081161","author":"N Kim","year":"2021","unstructured":"Kim N, Eum HH, Lee H-O (2021) Clinical perspectives of single-cell RNA sequencing. Biomolecules 11(8):1161. https:\/\/doi.org\/10.3390\/biom11081161","journal-title":"Biomolecules"},{"key":"6473_CR206","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.csbj.2022.12.049","volume":"21","author":"J Zhang","year":"2023","unstructured":"Zhang J et al (2023) Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues. Comput Struct Biotechnol J 21:665\u2013676","journal-title":"Comput Struct Biotechnol J"},{"key":"6473_CR207","doi-asserted-by":"publisher","first-page":"e2203040","DOI":"10.1002\/advs.202203040","volume":"9","author":"Z Ou","year":"2022","unstructured":"Ou Z et al (2022) Single-Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma. Adv Sci (Weinh) 9:e2203040","journal-title":"Adv Sci (Weinh)"},{"key":"6473_CR208","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s42003-022-04142-w","volume":"5","author":"C Li","year":"2022","unstructured":"Li C et al (2022) Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer. Commun Biol 5:1208","journal-title":"Commun Biol"},{"key":"6473_CR209","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.omtn.2021.03.017","volume":"24","author":"C Li","year":"2021","unstructured":"Li C, Guo L, Li S, Hua K (2021) Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in CC. Mol Ther Nucleic Acids 24:682\u2013694","journal-title":"Mol Ther Nucleic Acids"},{"key":"6473_CR210","doi-asserted-by":"publisher","first-page":"eadd8977","DOI":"10.1126\/sciadv.add8977","volume":"9","author":"C Liu","year":"2023","unstructured":"Liu C et al (2023) Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. Sci Adv 9:eadd8977","journal-title":"Sci Adv"},{"key":"6473_CR211","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stem.2021.03.012","volume":"28","author":"K L\u00f5hmussaar","year":"2021","unstructured":"L\u00f5hmussaar K et al (2021) Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. Cell Stem Cell 28:1380\u20131396e6","journal-title":"Cell Stem Cell"},{"key":"6473_CR212","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-016-0258-z","volume":"23","author":"AL Peres","year":"2016","unstructured":"Peres AL et al (2016) Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care. J Biomed Sci 23:42","journal-title":"J Biomed Sci"},{"key":"6473_CR213","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/modpathol.2013.166","volume":"27","author":"LF Escobar-Hoyos","year":"2014","unstructured":"Escobar-Hoyos LF et al (2014) Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker. Mod Pathol 27:621\u2013630","journal-title":"Mod Pathol"},{"key":"6473_CR214","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamainternmed.2019.0306","volume":"179","author":"N Wentzensen","year":"2019","unstructured":"Wentzensen N et al (2019) Clinical Evaluation of Human Papillomavirus Screening With p16\/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program. JAMA Intern Med 179:881\u2013888","journal-title":"JAMA Intern Med"},{"key":"6473_CR215","doi-asserted-by":"publisher","first-page":"24267","DOI":"10.1074\/jbc.M115.657270","volume":"290","author":"C Capparelli","year":"2015","unstructured":"Capparelli C, Rosenbaum S, Berger AC, Aplin AE (2015) Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanoma. J Biol Chem 290:24267\u201324277","journal-title":"J Biol Chem"},{"key":"6473_CR216","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ccell.2020.06.005","volume":"38","author":"Z Zhang","year":"2020","unstructured":"Zhang Z et al (2020) Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell 38:279\u2013296e9","journal-title":"Cancer Cell"},{"key":"6473_CR217","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41419-024-06522-y","volume":"15","author":"B Sheng","year":"2024","unstructured":"Sheng B et al (2024) Single-cell RNA sequencing of cervical exfoliated cells reveals potential biomarkers and cellular pathogenesis in cervical carcinogenesis. Cell Death Dis 15:130","journal-title":"Cell Death Dis"},{"key":"6473_CR218","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.7150\/thno.49547","volume":"11","author":"Y Zhu","year":"2021","unstructured":"Zhu Y et al (2021) Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer. Theranostics 11:2722\u20132741","journal-title":"Theranostics"},{"key":"6473_CR219","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41374-022-00733-7","volume":"102","author":"Y-L Wang","year":"2022","unstructured":"Wang Y-L et al (2022) STAT3 regulates SRGN and promotes metastasis of nasopharyngeal carcinoma through the FoxO1-miR-148a-5p-CREB1 axis. Lab Invest 102:919\u2013934","journal-title":"Lab Invest"},{"key":"6473_CR220","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/cas.15336","volume":"113","author":"Q Wang","year":"2022","unstructured":"Wang Q et al (2022) Histone H1.2 promotes hepatocarcinogenesis by regulating signal transducer and activator of transcription 3 signaling. Cancer Sci 113:1679\u20131692","journal-title":"Cancer Sci"},{"key":"6473_CR221","doi-asserted-by":"publisher","first-page":"e1219","DOI":"10.1002\/ctm2.1219","volume":"13","author":"C Guo","year":"2023","unstructured":"Guo C et al (2023) Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome. Clin Transl Med 13:e1219","journal-title":"Clin Transl Med"},{"key":"6473_CR222","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11010-025-05407-8","volume":"481","author":"C Pu","year":"2026","unstructured":"Pu C, Xing B, Wang S, Liu Z, Zhao Y (2026) Advancements in single-cell sequencing for cervical cancer research. Mol Cell Biochem 481:615\u2013637","journal-title":"Mol Cell Biochem"},{"key":"6473_CR223","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","volume":"12","author":"AJ Nirmal","year":"2022","unstructured":"Nirmal AJ et al (2022) The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution. Cancer Discov 12:1518\u20131541","journal-title":"Cancer Discov"},{"key":"6473_CR224","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/0008-5472.CAN-18-0747","volume":"78","author":"K Thrane","year":"2018","unstructured":"Thrane K, Eriksson H, Maaskola J, Hansson J, Lundeberg J (2018) Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma. Cancer Res 78:5970\u20135979","journal-title":"Cancer Res"},{"key":"6473_CR225","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.7150\/jca.114505","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y et al (2025) Multi-Omics Analysis Reveals the transforming growth factor-\u03b2 Signaling-Driven Multicellular Interactions with Prognostic Relevance in Cervical Cancer Progression. J Cancer 16:2857\u20132876","journal-title":"J Cancer"},{"key":"6473_CR226","doi-asserted-by":"crossref","unstructured":"Wang Y et al (2025) Applications and Prospects of Single-Cell RNA Sequencing and Spatial Transcriptomics in Cervical Cancer. Biomed Res. Int. 1532745 (2025)","DOI":"10.1155\/bmri\/1532745"},{"key":"6473_CR227","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-06011-y","volume":"22","author":"L Zhou","year":"2024","unstructured":"Zhou L et al (2024) Spatial transcriptomics reveals unique metabolic profile and key oncogenic regulators of cervical squamous cell carcinoma. J Transl Med 22:1163","journal-title":"J Transl Med"},{"key":"6473_CR228","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-025-03432-5","volume":"44","author":"Z Lin","year":"2025","unstructured":"Lin Z et al (2025) Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts. J Exp Clin Cancer Res 44:194","journal-title":"J Exp Clin Cancer Res"},{"key":"6473_CR229","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41698-025-00948-z","volume":"9","author":"P Xia","year":"2025","unstructured":"Xia P, Zhou J, Shen R, Wang D (2025) Deciphering the cellular and molecular landscape of cervical cancer progression through single-cell and spatial transcriptomics. NPJ Precis Oncol 9:158","journal-title":"NPJ Precis Oncol"},{"key":"6473_CR230","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/LGT.0000000000000334","volume":"21","author":"N Wentzensen","year":"2017","unstructured":"Wentzensen N et al (2017) ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice. J Low Genit Tract Dis 21:230\u2013234","journal-title":"J Low Genit Tract Dis"},{"key":"6473_CR231","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ajog.2006.01.091","volume":"195","author":"J Jeronimo","year":"2006","unstructured":"Jeronimo J, Schiffman M (2006) Colposcopy at a crossroads. Am J Obstet Gynecol 195:349\u2013353","journal-title":"Am J Obstet Gynecol"},{"key":"6473_CR232","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2017.18152","volume":"318","author":"DSW Ting","year":"2017","unstructured":"Ting DSW et al (2017) Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes. JAMA 318:2211\u20132223","journal-title":"JAMA"},{"key":"6473_CR233","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/jnci\/djy225","volume":"111","author":"L Hu","year":"2019","unstructured":"Hu L et al (2019) An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. J Natl Cancer Inst 111:923\u2013932","journal-title":"J Natl Cancer Inst"},{"key":"6473_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68252-3","volume":"10","author":"C Yuan","year":"2020","unstructured":"Yuan C et al (2020) The application of deep learning based diagnostic system to cervical squamous intraepithelial lesions recognition in colposcopy images. Sci Rep 10:11639","journal-title":"Sci Rep"},{"key":"6473_CR235","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ygyno.2020.07.099","volume":"159","author":"H Bao","year":"2020","unstructured":"Bao H et al (2020) Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study. Gynecol Oncol 159:171\u2013178","journal-title":"Gynecol Oncol"},{"key":"6473_CR236","doi-asserted-by":"publisher","first-page":"102052","DOI":"10.1016\/j.compmedimag.2022.102052","volume":"97","author":"D Brenes","year":"2022","unstructured":"Brenes D et al (2022) Multi-task network for automated analysis of high-resolution endomicroscopy images to detect cervical precancer and cancer. Comput Med Imaging Graph 97:102052","journal-title":"Comput Med Imaging Graph"},{"key":"6473_CR237","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1109\/TMI.2020.2994778","volume":"39","author":"Y Li","year":"2020","unstructured":"Li Y et al (2020) Computer-Aided Cervical Cancer Diagnosis Using Time-Lapsed Colposcopic Images. IEEE Trans Med Imaging 39:3403\u20133415","journal-title":"IEEE Trans Med Imaging"},{"key":"6473_CR238","doi-asserted-by":"publisher","first-page":"104209","DOI":"10.1016\/j.compbiomed.2021.104209","volume":"130","author":"G Peng","year":"2021","unstructured":"Peng G, Dong H, Liang T, Li L, Liu J (2021) Diagnosis of cervical precancerous lesions based on multimodal feature changes. Comput Biol Med 130:104209","journal-title":"Comput Biol Med"},{"key":"6473_CR239","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e57","volume":"33","author":"T Takahashi","year":"2022","unstructured":"Takahashi T et al (2022) Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis. J Gynecol Oncol 33:e57","journal-title":"J Gynecol Oncol"},{"key":"6473_CR240","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/ijc.33029","volume":"147","author":"Z Xue","year":"2020","unstructured":"Xue Z et al (2020) A demonstration of automated visual evaluation of cervical images taken with a smartphone camera. Int J Cancer 147:2416\u20132423","journal-title":"Int J Cancer"},{"key":"6473_CR241","doi-asserted-by":"publisher","first-page":"104675","DOI":"10.1016\/j.ijmedinf.2021.104675","volume":"159","author":"L Fu","year":"2022","unstructured":"Fu L et al (2022) Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test. Int J Med Inf 159:104675","journal-title":"Int J Med Inf"},{"key":"6473_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10121424","author":"J Tang","year":"2023","unstructured":"Tang J, Zhang T, Gong Z, Huang X (2023) High precision cervical precancerous lesion classification method based on ConvNeXt. Bioengineering (Basel) 10(12):1424. https:\/\/doi.org\/10.3390\/bioengineering10121424","journal-title":"Bioengineering (Basel)"},{"key":"6473_CR243","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s12885-025-13926-2","volume":"25","author":"Z Taghados","year":"2025","unstructured":"Taghados Z, Azimifar Z, Monsefi M, Jahromi MA (2025) CausalCervixNet: convolutional neural networks with causal insight (CICNN) in cervical cancer cell classification-leveraging deep learning models for enhanced diagnostic accuracy. BMC Cancer 25:607","journal-title":"BMC Cancer"},{"key":"6473_CR244","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1002\/cam4.3296","volume":"9","author":"H Bao","year":"2020","unstructured":"Bao H et al (2020) The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women. Cancer Med 9:6896\u20136906","journal-title":"Cancer Med"},{"key":"6473_CR245","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1038\/s41467-025-62589-x","volume":"16","author":"J Bai","year":"2025","unstructured":"Bai J et al (2025) AI-assisted cervical cytology precancerous screening for high-risk population in resource-limited regions using a compact microscope. Nat Commun 16:7429","journal-title":"Nat Commun"},{"key":"6473_CR246","doi-asserted-by":"publisher","first-page":"105111","DOI":"10.1016\/j.compbiomed.2021.105111","volume":"140","author":"Z Salahuddin","year":"2022","unstructured":"Salahuddin Z, Woodruff HC, Chatterjee A, Lambin P (2022) Transparency of deep neural networks for medical image analysis: A review of interpretability methods. Comput Biol Med 140:105111","journal-title":"Comput Biol Med"},{"key":"6473_CR247","doi-asserted-by":"publisher","unstructured":"Das M (2021) WHO launches strategy to accelerate elimination of cervical cancer. The Lancet. Oncology 22:20\u201321 Preprint at https:\/\/doi.org\/10.1016\/S1470-2045(20)30729-4","DOI":"10.1016\/S1470-2045(20)30729-4"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06473-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:02:39Z","timestamp":1792263759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06473-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":247,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6473"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06473-x","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"383"}}